Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/GA/Augusta
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Augusta, GA

Studies commonly pay $75 to $4,500 per completed study

184 clinical trials are currently recruiting participants within 30 miles of Augusta. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

184studies recruiting
5+research centers nearby
3condition categories
Live from the NIH registry

Studies recruiting near Augusta right now

Top 25 of 184 recruiting studies, sorted by proximity — each links to its official registry page

Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer

Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 Phase 3 Interventional 428 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05646316)

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features Phase 3 Interventional 600 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06337318)

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University-Telemedicine — Augusta, Georgia (9.2 mi) · Sponsor: Sameek Roychowdhury
See eligibility & contact on ClinicalTrials.gov (NCT06906562)

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Solid Tumors, Hematologic Malignancies Phase 3 Interventional 3,500 participants sought
Augusta University ( Site 0077) — Augusta, Georgia (9.2 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT03486873)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm Phase 2 Interventional 2,000 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05564390)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma Phase 3 Interventional 255 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT07198074)

A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations

Parkinson Disease Phase 2 Interventional 150 participants sought
Augusta University Medical Center (Site #212) — Augusta, Georgia (9.2 mi) · Sponsor: Appello Pharmaceuticals, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07432958)

Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

Acute Myeloid Leukemia (AML) Phase 2 Interventional 108 participants sought
Georgia Cancer Center at Augusta University — Augusta, Georgia (9.2 mi) · Sponsor: Bio-Path Holdings, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT02781883)

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Endometrial Cancer Phase 3 Interventional 600 participants sought
Research Site — Augusta, Georgia (9.2 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06989112)

A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio

Geographic Atrophy Secondary to Age-related Macular Degeneration Phase 2 Interventional 240 participants sought
Southeast Retina Center — Augusta, Georgia (9.2 mi) · Sponsor: Apellis Pharmaceuticals, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07215390)

Type 1 Diabetes, Endothelin, and Skeletal Muscle Mitochondrial Dysfunction: The Role of Sirtuin-1

Type 1 Diabetes EARLY/Phase 1 Interventional 24 participants sought
Augusta University/Georgia Prevention Institute/ Laboratory of Integrative and Exercise Physiology — Augusta, Georgia (9.2 mi) · Sponsor: Augusta University
See eligibility & contact on ClinicalTrials.gov (NCT04449198)

A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia

B Acute Lymphoblastic Leukemia Associated With Down Syndrome, Down Syndrome N/A Observational 330 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT05702645)

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

B Acute Lymphoblastic Leukemia Phase 3 Interventional 303 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT03150693)

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

High Grade Osteosarcoma, Localized Osteosarcoma Phase 2, Phase 3 Interventional 1,122 participants sought
Augusta University Medical Center — Augusta, Georgia (9.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05691478)

Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration

Age-related Wet Macular Degeneration Phase 1 Interventional 45 participants sought
CBCC Global Research Site:001 — Augusta, Georgia (9.2 mi) · Sponsor: Caregen Co. Ltd.
See eligibility & contact on ClinicalTrials.gov (NCT06132035)

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Hematologic Malignancies, Inherited Disorders of Metabolism N/A Observational 99,999 participants sought
Georgia Cancer Center at Augusta University Health — Augusta, Georgia (9.2 mi) · Sponsor: Center for International Blood and Marrow Transplant Research
See eligibility & contact on ClinicalTrials.gov (NCT01351545)

A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis

Non-cystic Fibrosis Bronchiectasis Phase 2 Interventional 284 participants sought
Augusta University — Augusta, Georgia (9.2 mi) · Sponsor: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
See eligibility & contact on ClinicalTrials.gov (NCT06559150)

Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

Generalized Myasthenia Gravis N/A Observational 500 participants sought
Clinical Trial Site — Augusta, Georgia (9.2 mi) · Sponsor: Alexion Pharmaceuticals, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04202341)

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Acute Myeloid Leukemia, Mixed Lineage Leukemia Gene Mutation Phase 1 Interventional 420 participants sought
Georgia Cancer Center at Augusta University — Augusta, Georgia (9.2 mi) · Sponsor: Kura Oncology, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT05735184)

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

Schizophrenia, Schizoaffective Disorder Phase 4 Interventional 50 participants sought
Neurocrine Clinical Site — Augusta, Georgia (9.2 mi) · Sponsor: Neurocrine Biosciences
See eligibility & contact on ClinicalTrials.gov (NCT07105111)
Actively enrolling

Studies you may be able to join near Augusta

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research studies for chronic kidney disease

This research platform is enrolling Black and African American adults in eligible areas who have been diagnosed with chronic kidney disease. Compensation may be available. The study team confirms eligibility before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Augusta

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Southeastern Clinical Research Institute

1521 Anthony Rd, Augusta, GA 30904
(706) 922-3005

Masters of Clinical Research

1232 Augusta W Pkwy, Augusta, GA 30909
(706) 210-8890

Telemedicine & Advanced Technology Research Center (TATRC) Digital Health Innovation Center (DHIC)

300 E Hospital Rd, Fort Gordon, GA 30905
(301) 619-7927

Georgia Prevention Institute

★ 4.8
1499 Walton Wy, Augusta, GA 30912
(706) 721-4534
"A place for and of exercise and health that lives up to the standard of pushing yourself. I am still sore."
— Richard Drake, 4★

Georgia Cancer Center - M. Bert Storey Research Building

★ 5.0
1410 Laney Walker Blvd, Augusta, GA 30912
(706) 721-0570
"Such professional caring care throughout all stages of care - from physicians to auxiliary medical care to clinic and infusion nurses to medical assi…"
— Genie Fulcher, 5★

Clinical trials in Augusta: what's recruiting

The Augusta area currently has 184 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Augusta, the most active research areas are:

  • Cancer & Oncology15 studies
  • Brain & Mental Health2 studies
  • Diabetes & Metabolism1 studies

Every listing shows the study phase, the recruiting site and its distance from Augusta, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Augusta

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Augusta participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How do I join a study in Augusta, GA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Augusta?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Augusta?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Augusta.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Augusta typically complete one or two studies per year.

Paid clinical trials near Augusta

Other metros within reach

Columbia, SC194 Athens, GA74 Mauldin, SC376 Greenville, SC378 Spartanburg, SC363 Savannah, GA168 Macon, GA73 Warner Robins, GA73

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Augusta Chronic Kidney Disease (HealthMatch) in Augusta Bladder Issues Due To Spinal Cord Injury in Augusta All conditions

More of GA

Atlanta1,710 Savannah168 Gainesville157 Athens74 Macon73 Warner Robins73 Columbus68

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts